| 注册
首页|期刊导航|中国药业|药学服务干预用于2型糖尿病合并高血压治疗的价值分析

药学服务干预用于2型糖尿病合并高血压治疗的价值分析

廖晓棠

中国药业2018,Vol.27Issue(3):83-86,4.
中国药业2018,Vol.27Issue(3):83-86,4.DOI:10.3969/j.issn.1006-4931.2018.03.027

药学服务干预用于2型糖尿病合并高血压治疗的价值分析

Application Value of Pharmaceutical Care Intervention in the Treatment of Type 2Diabetic Mellitus with Hypertension

廖晓棠1

作者信息

  • 1. 湖南省药品审评认证与不良反应监测中心,湖南长沙 410013
  • 折叠

摘要

Abstract

Objective To investigate the application value of pharmaceutical care intervention in the treatment of type 2 diabetic mellitus ( T2DM ) complicated with hypertension. Methods Totally 45 patients with T2DM complicated with hypertension admitted to our hospital from January to October in 2016 were selected as the control group, which were given routine medication guidance, another 45 patients with T2DM complicated with hypertension admitted to our hospital from November 2016 to August 2017 were selected as the observation group, which were given pharmaceutical care intervention. Results After the intervention, the FBG and 2 hPG of the two groups were significantly lower than those before the intervention ( P < 0. 05 ) , and the decrease of the observation group was more significant than that of the control group ( P < 0. 05 ) . The systolic blood pressure and diastolic blood pressure of the two groups were significantly lower than those before the intervention ( P < 0. 05 ) , and the decrease of the observation group was more significant than that of the control group ( P < 0. 05 ) . The total compliance rate of the observation group was higher than that of the control group ( P < 0. 05 ) . Conclusion Pharmaceutical care intervention in the treatment of T2DM complicated with hypertension has high application value, it can effectively reduce the blood glucose and blood pressure level of the patients, and improve the compliance of the patients, which is worthy of clinical promotion.

关键词

2型糖尿病/高血压/药学服务/依从性

Key words

type 2 diabetes mellitus/hypertension/pharmaceutical care/compliance

分类

医药卫生

引用本文复制引用

廖晓棠..药学服务干预用于2型糖尿病合并高血压治疗的价值分析[J].中国药业,2018,27(3):83-86,4.

中国药业

OACSTPCD

1006-4931

访问量0
|
下载量0
段落导航相关论文